100 related articles for article (PubMed ID: 2175101)
21. [Immunocytochemical detection of creatine kinase isoenzymes (CK BB) in human cerebral cortex].
Makarenko IG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):38-42. PubMed ID: 1665650
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of CPK isoenzyme in head injury (author's transl)].
Takeda K; Tanaka Y; Katsurada K
No Shinkei Geka; 1981 Oct; 9(11):1237-40. PubMed ID: 7312117
[TBL] [Abstract][Full Text] [Related]
23. [Regulation of the activity of brain cytoplasmic creatine kinase by pyridine nucleotides].
Khvatova EM; Semenova TS
Vopr Med Khim; 1991; 37(4):31-3. PubMed ID: 1750206
[TBL] [Abstract][Full Text] [Related]
24. Oxidative modification of creatine kinase BB in Alzheimer's disease brain.
Aksenov M; Aksenova M; Butterfield DA; Markesbery WR
J Neurochem; 2000 Jun; 74(6):2520-7. PubMed ID: 10820214
[TBL] [Abstract][Full Text] [Related]
25. Creatine phosphokinase and schizophrenia in Singapore.
Tsoi WF; Candlish JK; Kua EH
Ann Acad Med Singap; 1985 Jan; 14(1):84-6. PubMed ID: 2860840
[TBL] [Abstract][Full Text] [Related]
26. [Creatine phosphokinase in the cerebrospinal fluid of patients with acute meningitis].
Smirnov VV; Skorniakov VI; Popov AS; Shestakova TI; Khot'ko LP
Vrach Delo; 1989 Jul; (7):112-3. PubMed ID: 2800482
[TBL] [Abstract][Full Text] [Related]
27. [Creatine kinase isoform B distribution in the brain in schizophrenia].
Savushkina OK; Tereshkina EB; Prokhorova TA; Vorobyeva EА; Boksha IS; Burbaeva GS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):62-68. PubMed ID: 27735901
[TBL] [Abstract][Full Text] [Related]
28. [Creatine phosphokinase activity and its isoenzymatic ratio in the myocardium in adaptation of the heart to prolonged loading].
Meerson FZ; Iavich MP
Vopr Med Khim; 1980; 26(5):599-605. PubMed ID: 7423872
[TBL] [Abstract][Full Text] [Related]
29. [A study on serum creatine phosphokinase and type A behavior in schizophrenia].
Wu YB
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):177-8, backcover. PubMed ID: 2591274
[TBL] [Abstract][Full Text] [Related]
30. Changes in serum total creatine phosphokinase (CPK) and its isoenzymes caused by experimental ligation of the superior mesenteric artery.
Graeber GM; Cafferty PJ; Reardon MJ; Curley CP; Ackerman NB; Harmon JW
Ann Surg; 1981 Apr; 193(4):499-505. PubMed ID: 7212812
[TBL] [Abstract][Full Text] [Related]
31. [Antigenic properties of BB creatine kinases from various tissues in hens].
Safronova TI; Ivanova SB; Lyzlova SN
Zh Evol Biokhim Fiziol; 1988; 24(6):835-41. PubMed ID: 2469265
[TBL] [Abstract][Full Text] [Related]
32. Effect of incubation in human plasma on electrophoretic mobility of brain-type creatine phosphokinase.
Cho HW; Meltzer HY; Joung JI; Goode D
Clin Chim Acta; 1976 Dec; 73(2):257-65. PubMed ID: 1000847
[TBL] [Abstract][Full Text] [Related]
33. Serum creatine phosphokinase in schizophrenia.
Meltzer HY
Am J Psychiatry; 1976 Feb; 133(2):192-7. PubMed ID: 1251926
[TBL] [Abstract][Full Text] [Related]
34. Intracellular alterations of the creatine kinase isoforms in brains of schizophrenic patients.
Klushnik TP; Spunde AYa ; Yakovlev AG; Khuchua ZA; Saks VA; Vartanyan ME
Mol Chem Neuropathol; 1991 Dec; 15(3):271-80. PubMed ID: 1807268
[TBL] [Abstract][Full Text] [Related]
35. Ultradian-infradian variation of cardiac creatine phosphokinase (CPK) activity in male Holtzman rats.
Marques N; Sánchez de la Peña S; Mushiya T; Yasmineh WG; Cornélissen G; Halberg F
Chronobiologia; 1994; 21(3-4):241-50. PubMed ID: 7729240
[TBL] [Abstract][Full Text] [Related]
36. [Age changes in properties of myofibrillary creatine phosphokinase enzyme in the rat myocardium during stress].
Shvets VN; Davydov VV; Makoed OB
Patol Fiziol Eksp Ter; 2000; (4):15-7. PubMed ID: 11247131
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting stability of isozymes of creatine phosphokinase.
Cho HW; Meltzer HY
Am J Clin Pathol; 1979 Jan; 71(1):75-82. PubMed ID: 420176
[TBL] [Abstract][Full Text] [Related]
38. Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit.
Streijger F; Oerlemans F; Ellenbroek BA; Jost CR; Wieringa B; Van der Zee CE
Behav Brain Res; 2005 Feb; 157(2):219-34. PubMed ID: 15639173
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis.
Ajani AE; Waksman R; Sharma AK; Lew R; Pinnow E; Canos DA; Cheneau E; Castagna M; Cha DH; Leborgne L; Satler LF; Pichard AD; Kent KM; Lindsay J
Am J Cardiol; 2004 Feb; 93(3):313-7. PubMed ID: 14759380
[TBL] [Abstract][Full Text] [Related]
40. Creatine phosphokinase in long-term dialysis patients.
Soffer O; Fellner SK; Rush RL
Arch Intern Med; 1981 Feb; 141(2):181-8. PubMed ID: 7458513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
